CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. AGREEMENT AND PLAN OF MERGER BY AND AMONG SUPERNUS PHARMACEUTICALS, INC. SUPERNUS MERGER SUB, INC. BISCAYNE NEUROTHERAPEUTICS,...Agreement and Plan of Merger • November 9th, 2018 • Supernus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER, dated as of September 12, 2018 (this “Agreement”), is entered into by and among SUPERNUS PHARMACEUTICALS, INC., a Delaware corporation (“Parent”), SUPERNUS MERGER SUB, INC., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), BISCAYNE NEUROTHERAPEUTICS, INC., a Florida corporation (the “Company”), and REICH CONSULTING GROUP, INC., a Florida corporation, as the Securityholder Representative (the “Securityholder Representative”).
